https://mqvlab.com/Recent content on MQV LabHugo -- gohugo.iomathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/news/Mon, 05 Jun 2023 23:14:42 -0400mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/news/June 5, 2023: The lab will officially launch at the Département d’immunologie et biologie cellulaire at the Université de Sherbrooke on September 1, 2023. We will be located at the Pavillon de recherche appliquée sur le cancer (PRAC) on the Health Campus. May 11, 2023: Mathieu will be attending ISMB2023 in Lyon and giving a talk at the iRNA COSI.https://mqvlab.com/about/Mon, 05 Jun 2023 22:34:08 -0400mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/about/Left to right: Juan, Nassima, Mikel, Léo, Tony, Emma, Mathieu Mathieu Quesnel-Vallières, Ph.D. he/him; last name pronunciation: “ken-el val-e-air” Assistant Professor Department of Immunology and Cell Biology, Université de Sherbrooke The list of biology fields that my research has involved at one point or another is too long to post here. Let’s say I know very little about a lot of things. On the daily: If you wonder whether I’m being serious, I’m not.https://mqvlab.com/contact/Mon, 05 Jun 2023 22:31:58 -0400mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/contact/The lab is located at the Université de Sherbrooke’s Cancer Research Institute (IRCUS) on the Health Campus, in beautiful Eastern Townships. Please direct questions and inquiries directly to Prof. Mathieu Quesnel-Vallières. mathieu.quesnel-vallieres[at]usherbrooke.ca Office: 1-819-821-8000 x72370 Student office: 1-819-821-8000 x70464 Lab: Z8-2034 Office: Z8-2025 Student office: Z8-1071 3201 rue Jean-Mignault Sherbrooke, QC Canada J1E 4K8https://mqvlab.com/projects/Mon, 05 Jun 2023 22:31:35 -0400mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/projects/Research should be impactful, novel and exciting. What will you discover? Precision cancer immunotherapy A set of new cancer therapies rely on the targeting of markers present at the surface of cancer cells using chimeric antigen receptor T cells, antibody-drug conjugates or vaccines. The application of these revolutionary approaches is limited in part by the lack of cancer-specific markers to target. Aberrant RNA splicing is a hallmark of all cancer types (e.https://mqvlab.com/positions/Mon, 05 Jun 2023 22:31:23 -0400mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/positions/Come work with us! We generally have one to two positions for grad students or postdocs available each year. Applicants seeking to conduct computational and/or experimental research are welcome to apply. Depending on the project, applicants with a background in molecular biology, cell biology, cancer, genetics, RNA biology, immunology or bioinformatics could be a good fit. CO-OP STUDENTS: openings will not be posted on the Trivio system. Please contact us to inquire about internship opportunities at least two semesters ahead of your expected internship start date.https://mqvlab.com/publications/Mon, 01 Jan 0001 00:00:00 +0000mathieu.quesnel-vallieres@usherbrooke.ca (Mathieu Quesnel-Vallières)https://mqvlab.com/publications/Cancer transcriptomics and splicing in cancer 2025 NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas. Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A